LEE WILLIS C
CEO
LEE WILLIS C has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, LEE WILLIS C is listed as CEO at Emmaus Life Sciences, Inc. Inside the rolling window, LEE WILLIS C reported 6 open-market purchases totaling $18K in EMMA and no open-market sales. The largest disclosed transaction in the window is a purchase of 94,767 EMMA shares on Aug 28, 2026, worth $6K.
Companies traded
Insider Buying
$18K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LEE WILLIS C made?
LEE WILLIS C has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company since 2026.
Which companies does LEE WILLIS C trade?
LEE WILLIS C has filed SEC Form 4 disclosures for 1 company, including EMMA.
When was LEE WILLIS C's most recent SEC Form 4 filing?
LEE WILLIS C's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is LEE WILLIS C's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, LEE WILLIS C is listed as CEO.
What is LEE WILLIS C's total buy and sell value in the current window?
Inside the rolling retention window, LEE WILLIS C bought $18K and sold $0 based on SEC Form 4 filings.
What was LEE WILLIS C's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 94,767 EMMA shares on 2026-08-28, worth $6K, per SEC Form 4 filings.